Delivery Order SPE2DR25D3404-SPE2DR26F5W3A
Award Date 1/29/26
Potential Completion Date 1/30/26
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 28, 2026, by the Defense Logistics Agency for NovoLog 100 Unit/mL FlexPen 3mL insulin pens valued at $7,350.48. This is a firm fixed-price, non-set-aside competitive award with an ultimate completion date of January 29, 2026. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order falls under Amerisourcebergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order valued at $2,895.64 from the Defense Logistics Agency for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The contract was awarded on January 15, 2026, with an ultimate completion date of January 16, 2026, and carries a firm fixed-price structure with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,846.11 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This competitive, firm fixed-price delivery order, issued on July 11, 2025, with an ultimate completion date of July 14, 2025, represents a pharmaceutical supply transaction under the company's existing contract vehicle with DLA. The products will be delivered to AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $1,020.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens on January 15, 2026, with completion scheduled for January 16, 2026. The award was made on a non-set-aside, competitive basis to the Conshohocken, Pennsylvania-based pharmaceutical distributor. This delivery order represents a task order under AmerisourceBergen's parent company, Cencora, Inc.'s, significantly larger indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,907.36 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/ml FlexPen 3ml insulin pens, with a contract ceiling value of $1,434.47 and an ultimate completion date of January 15, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a routine pharmaceutical supply transaction under the company's broader federal medical contracting portfolio. The place of performance is AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $1,405.80 and an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively as a child contract under AmerisourceBergen's larger DLA prime vendor contract vehicle. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order valued at $1,373.04 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens on January 6, 2026, with an ultimate completion date of January 7, 2026. This competitive award, which carries no set-aside designation, represents a firm fixed-price transaction for pharmaceutical supplies to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,661.23 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with performance at the company's Conshohocken, Pennsylvania facility. This non-competitive delivery order, awarded January 16, 2026, represents a task order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The parent company, Cencora, Inc., holds a significant $999,999,999.00 IDC...
- On January 22, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $2,722.40 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 23, 2026. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...